<!DOCTYPE html>
<html dir="ltr" lang="en"><head><title>Featured Experts</title>
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="content-type" content="text/html; charset=utf-8" />
  <meta name="generator" content="The Grid the-composer/ds-d4/1.1.7">
  <meta name="the-grid-solution" content="4d73f9a7-1718-45da-b378-678dfe95263e">
  <script src="https://ajax.googleapis.com/ajax/libs/webfont/1.6.16/webfont.js"></script>
  <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/babel-polyfill/6.9.1/polyfill.js"></script>
  <link rel="stylesheet" href="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/assets/styles/css/style.css" type="text/css" />
  <link rel="stylesheet" href="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/assets/styles/css/animations.css" type="text/css" />
  <link rel="stylesheet" href="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/assets/styles/css/props.css" type="text/css" />
  <link rel="stylesheet" href="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/assets/styles/css/focalpoint.css" type="text/css" />
  <style id="web-font-binder" type="text/css">html { font-family: 'Georgia', 'Times New Roman', 'Times', 'serif';font-weight: 400; } html.wf-active { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif';font-weight: 400; } .wf-active .font-title, .wf-active .font-headline, .wf-active .font-h1, .wf-active .font-h2, .wf-active .font-h3 { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 900; } .wf-active .font-subtitle, .wf-active .font-h4, .wf-active .font-h5, .wf-active .font-h6 { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 900; } .wf-active .font-text, .wf-active .font-list { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif'; } .wf-active .font-quote { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 400;font-style: italic; } .wf-active .font-cta { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif'; }</style><link rel="alternate" type="application/rss+xml" title="RSS" href="./rss.xml"/></head><body><div id="app"><div id="wrapper" class="System color-bg Brockmann section-h-padding-small section-v-padding-small hero-transition-none m-t-4  colors-light colors-global " data-reactroot="" data-reactid="1" data-react-checksum="-987423014"><!-- react-empty: 2 --><section id="NavHamburger" class="Section Section--components-1 Section--nav color-box title-size-medium bx-sh-soft  colors-light colors-local " data-reactid="3"><div class="Component Nav--hamburger" data-reactid="4"><div class="Nav Icon z-30 color-icon t-1rem r-2rem pos-a cur-p f-s-m" data-reactid="5">☰</div><div class="Site-title color-text-pop pos-r t-1rem l-2rem f-s-m z-20" data-reactid="6"><span data-reactid="7"><!-- react-empty: 8 --><a href="index.html" data-reactid="9">Featured Experts</a></span></div><div class="Group Group--links p-l-1 ls-p-l-5 p-b-13 p-t-4 w-s-wrap f-s-m ls-f-s-l t-a-r" data-reactid="10"><div class="Link color-text-pop" data-reactid="11"><span data-reactid="12"><a href="meet-the-team" data-reactid="13">Meet the Team</a></span></div><div class="Link color-text-pop" data-reactid="14"><span data-reactid="15"><a href="contact-us" data-reactid="16">Contact Us</a></span></div><div class="Link color-text-pop" data-reactid="17"><span data-reactid="18"><a href="solutions" data-reactid="19">Solutions</a></span></div></div></div></section><div class="Items min-h-80vh" data-reactid="20"><section id="section-ArticleFallback-91d20fd0-2eb3-4156-beab-ff0f38e2aa29" class="Section Section--article color-bg color-title color-text w-100p p-1 ls-p-2  colors-dark colors-local " data-reactid="21"><div class="Component max-w-768px m-a pos-r p-2" data-reactid="22"><h1>Featured Experts</h1><h2>Let our team of experts be your go-to team for your next clinical trial</h2><p>Our multifunctional teams work side by side with you throughout the course of your trial. This unique 360º approach eliminates hand-off confusion and empowers you to make more informed decisions. Learn more about some of the experts that could become an extension of your team. </p><h2>Jack Modell, MD</h2><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300">
</picture>
<p>Dr. Modell is a board-certified psychiatrist with 30 years of experience in clinical research, teaching, and patient care including over 10 years of experience in clinical drug development (phases 1 through 4), medical affairs, successful NDA filings, medical governance, drug safety, compliance, and management in the pharmaceutical industry. His specialties and expertise include neuroscience, clinical pharmacology, drug development, clinical research, medical governance, teaching, and clinical diagnosis and treatment. Jack has authored over 50 peer-reviewed publications across numerous medical specialties, including addiction medicine, anesthesiology, neurology, nuclear medicine, and psychiatry. He has lead several successful development programs in the neurosciences. Jack is a key opinion leader in the neurosciences, has won numerous awards and honors for patient care and teaching, served on numerous advisory and editorial boards, and is nationally known for leading the first successful development of preventative pharmacotherapy for the depressive episodes of seasonal affective disorder.</p><h2>David Shoemaker, PhD</h2><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300">
</picture>
<p>In the past two years, Dr. Shoemaker has served as an expert reviewer for four successful marketing applications. Dr. Shoemaker has significant experience interacting with the Divisions of Anesthetics, Analgesia, and Addiction Products (DAAARP), Gastroenterology and Inborn Error Products (DGIEP), Bone and Reproductive & Urological Products (DBRUP), Dermatology and Dental Products (DDDP), Anti-infective Products (DAIP), Oncology Products (DOP), Hematology and Oncology Products (DHOP), Cardiovascular and Renal Products (DCRP), Pulmonology, Allergy, and Rheumatology Products (DPARP), and Neural Product (DNP) at the Center for Drug Evaluation and Research, and the Divisions of Cellular & Gene Therapeutics (DCGT), and Hematology Research and Review (DHRR) within the Center for Biologics Evaluation and Research at FDA and has obtained marketing approval for products in the US, Canada and the EU. He works closely with medical, biostatistics, clinical operations, and regulatory authors to ensure Rho’s effort reflects the advantages of his over 20 years marketing application experience. David has over 25 years of experience in research and pharmaceutical development. He has served as a Program Leader or Advisor for multidisciplinary, matrix management program teams and has been involved with products at all stages of the development process. Primarily, he has managed the regulatory strategy for programs in multiple therapeutic areas including the following: hematology, oncology, cardiology, pulmonology, infectious diseases, genetic enzyme deficiencies, antitoxins, and antibioterrorism agents. He has extensive experience in the preparation and filing of all types of regulatory submissions including primary responsibility for four BLAs and three NDAs. He has managed or contributed to over two dozen marketing applications including NDAs, BLAs, NDSs, and MAAs. He has moderated dozens of regulatory authority meetings for all stages of development. His primary areas of expertise include clinical study design and regulatory strategy for development of novel drug and biological products.</p><h2>Karl Whitney, PhD</h2><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300">
</picture>
<p>Dr. Whitney has almost 15 years of experience in the pharmaceutical industry, specializing in clinical and regulatory aspects of pharmaceutical development. During this time, he has led multiple integrated drug-development programs spanning the development spectrum by planning, managing, and overseeing concurrent manufacturing, nonclinical, clinical, and regulatory activities. Karl has also led the preparation of or helped prepare Investigational New Drug (IND) applications, clinical and nonclinical final study reports, pre-New Drug Application (NDA) meeting packages, annual reports, Investigator Brochures, Fast-Track and Orphan-Drug applications, NDAs in the electronic Common Technical Document (eCTD) format, and numerous other documents. He has provided strategic advice to clients on a broad array of drug development strategy issues. Karl’s therapeutic areas of expertise include CNS disorders such as pain, Huntington’s Disease, and schizophrenia, as well as hemophilia and tuberculosis. Through his doctoral and postdoctoral research, he has technical expertise in these areas as well as in neuroimmunology, nuclear hormone receptor biology, and various genomics research techniques.</p><h2>Carrie Furr, PhD</h2><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300">
</picture>
<p>Dr. Furr has over nine years of experience in regulatory affairs and integrated product development. She is experienced at authoring documents destined for successful regulatory authority filings, is a seasoned negotiator with the FDA, and has effectively guided multidisciplinary, multinational teams and vendors through nonclinical, clinical, CMC, and regulatory activities from Pre-IND through market authorization. She has managed and made crucial contributions to several INDs, as well as a BLA, ANDA, NDAs, and a NDS with the outcome of market approval. She has a proven ability to facilitate communication across global teams, while maintaining a clear focus on expectations, collaboration, budgets, timelines, and quality deliverables while identifying potential risks and contingency plans. Dr. Furr has also contributed to securing federal and state funding to bring a novel product from basic bench top research through its first-in-man clinical trial and has also obtained Orphan Drug designation for a novel gene therapy product. She has worked in the therapeutic areas of anti-infectives, immunology, CNS, endocrinology, ophthalmology, musculoskeletal disorders, respiratory diseases, cardiovascular diseases, oncology, dermatology, and gastrointestinal diseases. After earning her Ph.D. in biochemistry from Texas A&M University, she was selected for the Integrated Product Development Program at a large, global CRO. She earned Regulatory Affairs Certification from the Regulatory Affairs Professionals Society in 2009 and maintains active certification.</p><h2>Andrea Rossi Mospan, PhD</h2><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300">
</picture>
<p>Dr. Mospan has nine years of experience in the pharmaceutical industry. Dr. Mospan provides integrated product development services for products at various stages of development. She provides strategic intra-disciplinary program management of cross-functional teams and vendors, monitoring ongoing progress of key deliverables, identifying potential risks and contingency plans, and providing oversight of all disciplines of the product development team. Dr. Mospan also authors an array of regulatory and clinical documents. Prior to her tenure at Rho, Dr. Mospan worked at a mid-sized biopharmaceutical company where she collaborated with scientists and thought leaders on the design, development, implementation, and management of programs for lead compounds, including a novel inhaled therapeutic. Dr. Mospan has experience in a variety of therapeutic areas, including ophthalmology and respiratory disorders.</p><h2>Kristen Snipes</h2><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300">
</picture>
<p>Kristen Snipes has over 15 years of pharmaceutical industry experience primarily as a program manager or clinical operations lead. Since joining Rho in 2007, she has been involved in leading and coordinating all operational activities for complex trials. She has a wide range of therapeutic experience including CNS, cardiology, respiratory, periodontal disease, Sjögren’s syndrome, hematology, and oncology programs. Before joining Rho, Kristen worked for a small pharmaceutical company specializing in CNS disorders where she collaborated with scientists and thought leaders in the design, development, implementation and management of a program for a centrally acting alpha2 adrenergic agonist for the treatment of ADHD in children and adolescences. Most recently, she managed a Phase III pivotal study for the treatment of ADHD utilizing the laboratory classroom format. This study completed enrollment two weeks prior to the projected timelines. She is a seasoned team leader with training and mentoring experience having spearheaded multiple training programs in the areas of project and clinical operations management. Kristen has a strong understanding of all aspects of product development that has allowed her to successfully lead teams to meet timeline deliverables for various multi-center trials. She is ACRP and SOCRA certified as a Clinical Research Associate.</p><p>Jamie Arnott</p><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300">
</picture>
<p>Jamie Arnott has extensive experience from her clinical nursing background as well as both the CRO and sponsor perspective in the oversight and management of clinical trial operations and outsourcing with more than 10 years’ experience in project management and 20 years’ experience in healthcare as a practitioner and in clinical research work. Before joining Rho, Jamie was the Director of Clinical Trial Operations for a biotechnology company where she provided oversight and management for all clinical activity for up to four concurrent INDs. She has broad therapeutic experience in oncology, including ovarian cancer, hematological malignancies, and advanced solid tumors; in addition, she has recent experience managing two large phase III studies.</p><h2>Brett Gordon</h2><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300">
</picture>
<p>Brett Gordon has seventeen years of overall clinical development experience, including thirteen years in project management, encompassing trials of varying sizes and complexity, both domestically and internationally. He has extensive knowledge of clinical development for both drugs/biologics and medical devices, including initial development plan formulation, protocol writing, trial implementation, monitoring and delivery, clinical study report writing, and regulatory submission to support of marketing applications. Brett has worked across numerous therapeutic areas and in particular possesses in-depth CNS and neurological experience, having managed or monitored trials in epilepsy, ADHD, bipolar disorder, alcohol dependence, spinal cord injury, and pain (acute, chronic, neuropathic, and musculoskeletal).</p><h2>Lauren McGurk</h2><picture>
  <source media="(min-width: 1440px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300">
  <source media="(min-width: 1280px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300">
  <source media="(min-width: 720px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300">
  <source media="(min-width: 360px)" srcset="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300">
  <img src="https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300">
</picture>
<p>Lauren McGurk has over 17 years of industry and clinical research experience in all phases of development, serving in the roles of Lead/Senior CRA, Site Manager, and Auditor. Since joining Rho in 2011, she has been involved in leading and conducting the clinical monitoring efforts on a variety of complex trials including a suite of dental-themed studies, including but not limited to periodontitis, TMJ and oral health disparities, hypoparathyroidism, head and neck oncology, refractory oncology pain, and parotid dysfunction. In addition to her role as LCRA, she has extensive EDC experience in a host of electronic capture systems, and has served as a site trainer and “train the trainer” for monitoring and other staff. She is a seasoned clinical team leader with training and mentoring experience and serves as a clinical and regulatory resource for her teams. Lauren has a strong understanding of clinical trial operations and management that has allowed her to successfully lead clinical teams to meet data timeline deliverables for various multi-center trials. She is adept in all aspects of GCPs, regulatory requirements, and site management.</p></div></section></div><section id="Footer3col" class="Section Section--components-2 Section--footer color-bg color-title z-30 p-1 ls-p-h-2vw  colors-dark colors-local " data-reactid="23"><div class="fx-1 bd-none ls-bd-r ls-bd-w-1" data-reactid="24"><div class="Group Group-heading ls-p-r-4" data-reactid="25"><div class="Site-title color-text-pop" data-reactid="26"><span data-reactid="27"><!-- react-empty: 28 --><h2 data-reactid="29"><a href="index.html" data-reactid="30">Featured Experts</a></h2></span></div></div></div><div class="fx-1" data-reactid="31"><div class="Group Group--links" data-reactid="32"><div class="Group Group--links f-s-m ls-f-s-s w-s-wrap ls-w-s-nowrap" data-reactid="33"></div></div></div></section></div></div>
    <script src="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/assets/scripts/placeholder.js"></script>
    <script src="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/assets/scripts/hero-transition.js"></script>
    <script src="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/assets/scripts/slider.js"></script>
  <script src="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/assets/scripts/navHamburger.js"></script><script id="pageReactInitState">window.pageReactInitState = {"items":{"site-navigation-item":{"id":"site-navigation-item","index":0,"metadata":{"@type":"navigation","starred":true},"content":[{"id":"site-navigation-block","type":"navigation","_html":"","metadata":{"starred":true},"navigation":[{"href":"index.html","title":"Rho test site","rel":"home","type":"MainPage"},{"href":"meet-the-team/index.html","title":"Meet the Team","rel":"","type":"WebPage"},{"href":"contact-us/index.html","title":"Contact Us","rel":"","type":"WebPage"},{"href":"solutions/index.html","title":"Solutions","rel":"","type":"WebPage"}]}]},"91d20fd0-2eb3-4156-beab-ff0f38e2aa29":{"id":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","index":1,"created_by":"dc6bef21-7e20-4732-bcfa-e43d2d8cc714","updated_by":"dc6bef21-7e20-4732-bcfa-e43d2d8cc714","created_at":"2016-07-14T17:04:08.469Z","updated_at":"2016-07-15T01:49:26.339Z","published":true,"score":0,"path":"_posts/2016-07-14-featured-experts.md","_title":"Featured Experts","metadata":{"@type":"Article","url":"featured-experts/index.html","inLanguage":null,"starred":false,"inFeed":true,"hasPage":true,"inNav":false,"_description":"Our multifunctional teams work side by side with you throughout the course of your trial. This unique 360º approach eliminates hand-off confusion and empowers you to make more informed decisions. Learn more about some of the experts that could become an extension of your team. ","title":"Featured Experts","keywords":[]},"content":[{"id":"422a88f9-f3e7-46f7-8c57-85e3208a5468","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h1","src":null,"created_at":null,"updated_at":null,"_text":"Featured Experts","_html":"<h1>Featured Experts</h1>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":true,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"a0e27635-e948-4ab0-b851-a39729bdf359","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"Let our team of experts be your go-to team for your next clinical trial","_html":"<h2>Let our team of experts be your go-to team for your next clinical trial</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":true,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"b7a927de-6d23-41a3-afb8-d693a171c06b","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Our multifunctional teams work side by side with you throughout the course of your trial. This unique 360º approach eliminates hand-off confusion and empowers you to make more informed decisions. Learn more about some of the experts that could become an extension of your team. ","_html":"<p>Our multifunctional teams work side by side with you throughout the course of your trial. This unique 360º approach eliminates hand-off confusion and empowers you to make more informed decisions. Learn more about some of the experts that could become an extension of your team. </p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":true,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"5abf82fe-134d-4326-bea2-273ec505a580","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"Jack Modell, MD","_html":"<h2>Jack Modell, MD</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"28d20fdb-ba01-4866-822b-97ff6172aca6","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/b3cdedab-b9f7-4683-a36c-809b61173797.jpg","starred":false,"_description":""},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/b3cdedab-b9f7-4683-a36c-809b61173797.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/b3cdedab-b9f7-4683-a36c-809b61173797.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/2bdd9cdddd00ae5a5ed6510c13481f99/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fb3cdedab-b9f7-4683-a36c-809b61173797.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/cd65229a9df851418e1cb3b1750d9dff.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":91,"y":71,"width":120,"height":120,"confidence":5.028373}],"colors":[[169,219,230],[6,12,2],[212,184,181],[68,107,50],[145,118,99]],"saliency":{"bounding_rect":[[1,1],[299,299]],"confidence":0.328046,"center":[149,186],"radius":191.331},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":3840,"XPKeywords":114,"ExifOffset":2388,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2014:08:01 23:27:06","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":5760,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":5112},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":5252,"ThumbnailLength":4672},"exif":{"ExposureCompensation":[],"ApertureValue":3,"ColorSpace":65535,"ISO":400,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2014:07:30 16:42:03","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2014:07:30 16:42:03","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"11","FNumber":2.8,"RecommendedExposureIndex":400,"InteropOffset":4998,"Flash":16,"ExifImageHeight":3840,"WhiteBalance":[],"OffsetSchema":4030,"ExposureTime":0.0015625,"SceneCaptureType":[],"ShutterSpeedValue":9.375,"SensitivityType":2,"ExifImageWidth":5760,"LensSerialNumber":"0000415563","MeteringMode":5,"SerialNumber":"022031005945","ExposureProgram":1,"SubSecTime":"11","OwnerName":"","SubSecTimeDigitized":"11"},"gps":{"GPSVersionID":[2,3]},"interoperability":{},"makernote":{}}}}},{"id":"c734b233-bf2f-492f-b207-0871f80e44c3","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Dr. Modell is a board-certified psychiatrist with 30 years of experience in clinical research, teaching, and patient care including over 10 years of experience in clinical drug development (phases 1 through 4), medical affairs, successful NDA filings, medical governance, drug safety, compliance, and management in the pharmaceutical industry. His specialties and expertise include neuroscience, clinical pharmacology, drug development, clinical research, medical governance, teaching, and clinical diagnosis and treatment. Jack has authored over 50 peer-reviewed publications across numerous medical specialties, including addiction medicine, anesthesiology, neurology, nuclear medicine, and psychiatry. He has lead several successful development programs in the neurosciences. Jack is a key opinion leader in the neurosciences, has won numerous awards and honors for patient care and teaching, served on numerous advisory and editorial boards, and is nationally known for leading the first successful development of preventative pharmacotherapy for the depressive episodes of seasonal affective disorder.","_html":"<p>Dr. Modell is a board-certified psychiatrist with 30 years of experience in clinical research, teaching, and patient care including over 10 years of experience in clinical drug development (phases 1 through 4), medical affairs, successful NDA filings, medical governance, drug safety, compliance, and management in the pharmaceutical industry. His specialties and expertise include neuroscience, clinical pharmacology, drug development, clinical research, medical governance, teaching, and clinical diagnosis and treatment. Jack has authored over 50 peer-reviewed publications across numerous medical specialties, including addiction medicine, anesthesiology, neurology, nuclear medicine, and psychiatry. He has lead several successful development programs in the neurosciences. Jack is a key opinion leader in the neurosciences, has won numerous awards and honors for patient care and teaching, served on numerous advisory and editorial boards, and is nationally known for leading the first successful development of preventative pharmacotherapy for the depressive episodes of seasonal affective disorder.</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"f5cd56fd-c0fd-4f4d-ac22-728b79bcd71d","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"David Shoemaker, PhD","_html":"<h2>David Shoemaker, PhD</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"ed2b9e5c-6d6d-4d95-8920-f6ff81e6d2bd","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/6313f4a3-da4b-4025-a45e-93611bf708f1.jpg","inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/6313f4a3-da4b-4025-a45e-93611bf708f1.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/6313f4a3-da4b-4025-a45e-93611bf708f1.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/f50f55b9277c4d39d86fcf2c2109c27f/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F6313f4a3-da4b-4025-a45e-93611bf708f1.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/60b68227e22bfa3d88ffd2ab5aef4474.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":71,"y":91,"width":120,"height":120,"confidence":5.025996}],"colors":[[254,255,255],[6,8,7],[203,146,126],[164,108,83],[185,193,156]],"saliency":{"bounding_rect":[[31,170],[299,299]],"confidence":0.311247,"center":[164,274],"radius":139.444},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":5760,"ExifOffset":304,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2016:06:29 23:30:29","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":3840,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":996},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":1110,"ThumbnailLength":5466},"exif":{"SubjectDistance":1.11,"ExposureCompensation":[],"ApertureValue":2.625,"ColorSpace":1,"ISO":100,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2016:06:16 09:03:42","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2016:06:16 09:03:42","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"06","FNumber":2.5,"RecommendedExposureIndex":100,"InteropOffset":870,"Flash":16,"ExifImageHeight":5760,"WhiteBalance":[],"ExposureTime":0.003125,"SceneCaptureType":[],"ShutterSpeedValue":8.375,"SensitivityType":2,"ExifImageWidth":3840,"LensSerialNumber":"0000415563","MeteringMode":5,"MaxApertureValue":0.625,"SerialNumber":"022031005945","ExposureProgram":1,"SubSecTime":"06","OwnerName":"","SubSecTimeDigitized":"06"},"gps":{"GPSVersionID":[2,3]},"interoperability":{"InteropIndex":"R98"},"makernote":{}}}}},{"id":"84e34ab4-3e33-4204-8ab4-52dcd6dd9039","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"In the past two years, Dr. Shoemaker has served as an expert reviewer for four successful marketing applications. Dr. Shoemaker has significant experience interacting with the Divisions of Anesthetics, Analgesia, and Addiction Products (DAAARP), Gastroenterology and Inborn Error Products (DGIEP), Bone and Reproductive & Urological Products (DBRUP), Dermatology and Dental Products (DDDP), Anti-infective Products (DAIP), Oncology Products (DOP), Hematology and Oncology Products (DHOP), Cardiovascular and Renal Products (DCRP), Pulmonology, Allergy, and Rheumatology Products (DPARP), and Neural Product (DNP) at the Center for Drug Evaluation and Research, and the Divisions of Cellular & Gene Therapeutics (DCGT), and Hematology Research and Review (DHRR) within the Center for Biologics Evaluation and Research at FDA and has obtained marketing approval for products in the US, Canada and the EU. He works closely with medical, biostatistics, clinical operations, and regulatory authors to ensure Rho’s effort reflects the advantages of his over 20 years marketing application experience. David has over 25 years of experience in research and pharmaceutical development. He has served as a Program Leader or Advisor for multidisciplinary, matrix management program teams and has been involved with products at all stages of the development process. Primarily, he has managed the regulatory strategy for programs in multiple therapeutic areas including the following: hematology, oncology, cardiology, pulmonology, infectious diseases, genetic enzyme deficiencies, antitoxins, and antibioterrorism agents. He has extensive experience in the preparation and filing of all types of regulatory submissions including primary responsibility for four BLAs and three NDAs. He has managed or contributed to over two dozen marketing applications including NDAs, BLAs, NDSs, and MAAs. He has moderated dozens of regulatory authority meetings for all stages of development. His primary areas of expertise include clinical study design and regulatory strategy for development of novel drug and biological products.","_html":"<p>In the past two years, Dr. Shoemaker has served as an expert reviewer for four successful marketing applications. Dr. Shoemaker has significant experience interacting with the Divisions of Anesthetics, Analgesia, and Addiction Products (DAAARP), Gastroenterology and Inborn Error Products (DGIEP), Bone and Reproductive & Urological Products (DBRUP), Dermatology and Dental Products (DDDP), Anti-infective Products (DAIP), Oncology Products (DOP), Hematology and Oncology Products (DHOP), Cardiovascular and Renal Products (DCRP), Pulmonology, Allergy, and Rheumatology Products (DPARP), and Neural Product (DNP) at the Center for Drug Evaluation and Research, and the Divisions of Cellular & Gene Therapeutics (DCGT), and Hematology Research and Review (DHRR) within the Center for Biologics Evaluation and Research at FDA and has obtained marketing approval for products in the US, Canada and the EU. He works closely with medical, biostatistics, clinical operations, and regulatory authors to ensure Rho’s effort reflects the advantages of his over 20 years marketing application experience. David has over 25 years of experience in research and pharmaceutical development. He has served as a Program Leader or Advisor for multidisciplinary, matrix management program teams and has been involved with products at all stages of the development process. Primarily, he has managed the regulatory strategy for programs in multiple therapeutic areas including the following: hematology, oncology, cardiology, pulmonology, infectious diseases, genetic enzyme deficiencies, antitoxins, and antibioterrorism agents. He has extensive experience in the preparation and filing of all types of regulatory submissions including primary responsibility for four BLAs and three NDAs. He has managed or contributed to over two dozen marketing applications including NDAs, BLAs, NDSs, and MAAs. He has moderated dozens of regulatory authority meetings for all stages of development. His primary areas of expertise include clinical study design and regulatory strategy for development of novel drug and biological products.</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"52a0be36-0bd5-40c4-9d06-360ed7c85481","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"Karl Whitney, PhD","_html":"<h2>Karl Whitney, PhD</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"75891acc-4bd5-49ce-97dc-44861e623472","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg","inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/978a155755b28e5cbc61185427099bf3/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F24e0bd0a-30f1-415d-bdb2-99f48f25ad61.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/e2c1480fc05eec71cebe96e541d6af4a.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":68,"y":80,"width":135,"height":135,"confidence":5.010813}],"colors":[[138,177,84],[255,229,255],[12,15,6],[95,127,52],[90,39,48]],"saliency":{"bounding_rect":[[1,8],[249,299]],"confidence":0.284696,"center":[124,169],"radius":183.596},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":5760,"XPKeywords":114,"ExifOffset":2388,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2012:05:03 23:34:49","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":3840,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":5112},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":5246,"ThumbnailLength":4879},"exif":{"ExposureCompensation":[],"ApertureValue":2.375,"ColorSpace":1,"ISO":100,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2012:04:23 16:02:29","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2012:04:23 16:02:29","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"26","FNumber":2.2,"RecommendedExposureIndex":100,"InteropOffset":4998,"Flash":16,"ExifImageHeight":5760,"WhiteBalance":[],"OffsetSchema":4088,"ExposureTime":0.0025,"SceneCaptureType":[],"ShutterSpeedValue":8.625,"SensitivityType":2,"ExifImageWidth":3840,"LensSerialNumber":"0000415563","MeteringMode":5,"SerialNumber":"022031005945","ExposureProgram":1,"SubSecTime":"26","OwnerName":"","SubSecTimeDigitized":"26"},"gps":{"GPSVersionID":[2,3]},"interoperability":{},"makernote":{}}}}},{"id":"f32e0e38-50a7-4678-99b6-08dc66df58d9","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Dr. Whitney has almost 15 years of experience in the pharmaceutical industry, specializing in clinical and regulatory aspects of pharmaceutical development. During this time, he has led multiple integrated drug-development programs spanning the development spectrum by planning, managing, and overseeing concurrent manufacturing, nonclinical, clinical, and regulatory activities. Karl has also led the preparation of or helped prepare Investigational New Drug (IND) applications, clinical and nonclinical final study reports, pre-New Drug Application (NDA) meeting packages, annual reports, Investigator Brochures, Fast-Track and Orphan-Drug applications, NDAs in the electronic Common Technical Document (eCTD) format, and numerous other documents. He has provided strategic advice to clients on a broad array of drug development strategy issues. Karl’s therapeutic areas of expertise include CNS disorders such as pain, Huntington’s Disease, and schizophrenia, as well as hemophilia and tuberculosis. Through his doctoral and postdoctoral research, he has technical expertise in these areas as well as in neuroimmunology, nuclear hormone receptor biology, and various genomics research techniques.","_html":"<p>Dr. Whitney has almost 15 years of experience in the pharmaceutical industry, specializing in clinical and regulatory aspects of pharmaceutical development. During this time, he has led multiple integrated drug-development programs spanning the development spectrum by planning, managing, and overseeing concurrent manufacturing, nonclinical, clinical, and regulatory activities. Karl has also led the preparation of or helped prepare Investigational New Drug (IND) applications, clinical and nonclinical final study reports, pre-New Drug Application (NDA) meeting packages, annual reports, Investigator Brochures, Fast-Track and Orphan-Drug applications, NDAs in the electronic Common Technical Document (eCTD) format, and numerous other documents. He has provided strategic advice to clients on a broad array of drug development strategy issues. Karl’s therapeutic areas of expertise include CNS disorders such as pain, Huntington’s Disease, and schizophrenia, as well as hemophilia and tuberculosis. Through his doctoral and postdoctoral research, he has technical expertise in these areas as well as in neuroimmunology, nuclear hormone receptor biology, and various genomics research techniques.</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"a8969506-c728-4768-bad2-d4e8de897078","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"Carrie Furr, PhD","_html":"<h2>Carrie Furr, PhD</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"17dfaf33-1d2b-4195-be52-28fbeace7ecb","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/935d3d3e-de5a-4afb-bb37-48ab79185250.jpg","inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/935d3d3e-de5a-4afb-bb37-48ab79185250.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/935d3d3e-de5a-4afb-bb37-48ab79185250.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/a0e0c5e80fcc5bb72964237cff994b16/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F935d3d3e-de5a-4afb-bb37-48ab79185250.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/2df3acf8a42bb8af606f6bef4ff977af.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":80,"y":91,"width":135,"height":135,"confidence":5.034093}],"colors":[[16,23,31],[47,63,63],[193,166,173],[217,205,219],[98,117,121]],"saliency":{"bounding_rect":[[88,64],[243,299]],"confidence":0.557072,"center":[157,181],"radius":123.562},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":5760,"XPKeywords":109,"ExifOffset":2388,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2014:04:09 23:33:36","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":3840,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":5112},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":5246,"ThumbnailLength":3669},"exif":{"ExposureCompensation":[],"ApertureValue":2.625,"ColorSpace":1,"ISO":125,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2014:03:26 09:47:05","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2014:03:26 09:47:05","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"95","FNumber":2.5,"RecommendedExposureIndex":125,"InteropOffset":4998,"Flash":16,"ExifImageHeight":5760,"WhiteBalance":[],"OffsetSchema":4088,"ExposureTime":0.005,"SceneCaptureType":[],"ShutterSpeedValue":7.625,"SensitivityType":2,"ExifImageWidth":3840,"LensSerialNumber":"0000415563","MeteringMode":5,"SerialNumber":"022031005945","ExposureProgram":1,"SubSecTime":"95","OwnerName":"","SubSecTimeDigitized":"95"},"gps":{"GPSVersionID":[2,3]},"interoperability":{},"makernote":{}}}}},{"id":"ad0bd231-4955-455d-8120-d76358297770","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Dr. Furr has over nine years of experience in regulatory affairs and integrated product development. She is experienced at authoring documents destined for successful regulatory authority filings, is a seasoned negotiator with the FDA, and has effectively guided multidisciplinary, multinational teams and vendors through nonclinical, clinical, CMC, and regulatory activities from Pre-IND through market authorization. She has managed and made crucial contributions to several INDs, as well as a BLA, ANDA, NDAs, and a NDS with the outcome of market approval. She has a proven ability to facilitate communication across global teams, while maintaining a clear focus on expectations, collaboration, budgets, timelines, and quality deliverables while identifying potential risks and contingency plans. Dr. Furr has also contributed to securing federal and state funding to bring a novel product from basic bench top research through its first-in-man clinical trial and has also obtained Orphan Drug designation for a novel gene therapy product. She has worked in the therapeutic areas of anti-infectives, immunology, CNS, endocrinology, ophthalmology, musculoskeletal disorders, respiratory diseases, cardiovascular diseases, oncology, dermatology, and gastrointestinal diseases. After earning her Ph.D. in biochemistry from Texas A&M University, she was selected for the Integrated Product Development Program at a large, global CRO. She earned Regulatory Affairs Certification from the Regulatory Affairs Professionals Society in 2009 and maintains active certification.","_html":"<p>Dr. Furr has over nine years of experience in regulatory affairs and integrated product development. She is experienced at authoring documents destined for successful regulatory authority filings, is a seasoned negotiator with the FDA, and has effectively guided multidisciplinary, multinational teams and vendors through nonclinical, clinical, CMC, and regulatory activities from Pre-IND through market authorization. She has managed and made crucial contributions to several INDs, as well as a BLA, ANDA, NDAs, and a NDS with the outcome of market approval. She has a proven ability to facilitate communication across global teams, while maintaining a clear focus on expectations, collaboration, budgets, timelines, and quality deliverables while identifying potential risks and contingency plans. Dr. Furr has also contributed to securing federal and state funding to bring a novel product from basic bench top research through its first-in-man clinical trial and has also obtained Orphan Drug designation for a novel gene therapy product. She has worked in the therapeutic areas of anti-infectives, immunology, CNS, endocrinology, ophthalmology, musculoskeletal disorders, respiratory diseases, cardiovascular diseases, oncology, dermatology, and gastrointestinal diseases. After earning her Ph.D. in biochemistry from Texas A&M University, she was selected for the Integrated Product Development Program at a large, global CRO. She earned Regulatory Affairs Certification from the Regulatory Affairs Professionals Society in 2009 and maintains active certification.</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"9464146a-e529-4d2b-af13-889f0f798a1e","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"Andrea Rossi Mospan, PhD","_html":"<h2>Andrea Rossi Mospan, PhD</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"eecbf8c8-2382-4e1b-9270-2938798601bf","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg","inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/450e1333af126d1bafe7c0f3d7629c3e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F0bcb2f14-7dd0-49b8-a167-5c1863299562.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/be82eb4acd9fe5e3279bcdf2ef739a66.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":100,"y":85,"width":85,"height":85,"confidence":5.036308}],"colors":[[12,16,19],[224,220,235],[93,78,71],[195,164,144],[114,167,85]],"saliency":{"bounding_rect":[[35,55],[299,299]],"confidence":0.246597,"center":[150,191],"radius":144.31},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":3840,"XPKeywords":97,"ExifOffset":2388,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2014:08:18 22:43:30","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":5760,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":5112},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":5248,"ThumbnailLength":5813},"exif":{"ExposureCompensation":[],"ApertureValue":3,"ColorSpace":1,"ISO":800,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2014:08:12 09:17:06","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2014:08:12 09:17:06","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"77","FNumber":2.8,"RecommendedExposureIndex":800,"InteropOffset":4998,"Flash":16,"ExifImageHeight":3840,"WhiteBalance":[],"OffsetSchema":4030,"ExposureTime":0.005,"SceneCaptureType":[],"ShutterSpeedValue":7.625,"SensitivityType":2,"ExifImageWidth":5760,"LensSerialNumber":"0000415563","MeteringMode":5,"SerialNumber":"022031005945","ExposureProgram":1,"SubSecTime":"77","OwnerName":"","SubSecTimeDigitized":"77"},"gps":{"GPSVersionID":[2,3]},"interoperability":{},"makernote":{}}}}},{"id":"50bd9c0e-72dc-4f54-a2bf-3707dd8caa0f","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Dr. Mospan has nine years of experience in the pharmaceutical industry. Dr. Mospan provides integrated product development services for products at various stages of development. She provides strategic intra-disciplinary program management of cross-functional teams and vendors, monitoring ongoing progress of key deliverables, identifying potential risks and contingency plans, and providing oversight of all disciplines of the product development team. Dr. Mospan also authors an array of regulatory and clinical documents. Prior to her tenure at Rho, Dr. Mospan worked at a mid-sized biopharmaceutical company where she collaborated with scientists and thought leaders on the design, development, implementation, and management of programs for lead compounds, including a novel inhaled therapeutic. Dr. Mospan has experience in a variety of therapeutic areas, including ophthalmology and respiratory disorders.","_html":"<p>Dr. Mospan has nine years of experience in the pharmaceutical industry. Dr. Mospan provides integrated product development services for products at various stages of development. She provides strategic intra-disciplinary program management of cross-functional teams and vendors, monitoring ongoing progress of key deliverables, identifying potential risks and contingency plans, and providing oversight of all disciplines of the product development team. Dr. Mospan also authors an array of regulatory and clinical documents. Prior to her tenure at Rho, Dr. Mospan worked at a mid-sized biopharmaceutical company where she collaborated with scientists and thought leaders on the design, development, implementation, and management of programs for lead compounds, including a novel inhaled therapeutic. Dr. Mospan has experience in a variety of therapeutic areas, including ophthalmology and respiratory disorders.</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"6cdf3d4e-e484-421d-9b06-675a5d60acc1","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"Kristen Snipes","_html":"<h2>Kristen Snipes</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"4d6b33a3-ed4a-4c4c-8707-29ffc6d4506f","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/7a0d9750-a87a-4297-ab5a-b7a353622218.jpg","inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/7a0d9750-a87a-4297-ab5a-b7a353622218.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/7a0d9750-a87a-4297-ab5a-b7a353622218.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/71fc360b72e7fbf813cef3ace0ecd26e/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F7a0d9750-a87a-4297-ab5a-b7a353622218.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/7433b82ed475d15861fde9cad9f90a5e.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":81,"y":81,"width":107,"height":107,"confidence":5.031521}],"colors":[[240,220,232],[4,5,0],[47,99,60],[125,181,152],[128,84,221]],"saliency":{"bounding_rect":[[77,33],[224,294]],"confidence":0.211762,"center":[148,163],"radius":134.067},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":3840,"XPKeywords":106,"ExifOffset":2388,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2015:06:19 09:11:14","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":5760,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":5112},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":5244,"ThumbnailLength":5327},"exif":{"ExposureCompensation":[],"ApertureValue":2.375,"ColorSpace":1,"ISO":200,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2015:06:10 09:17:06","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2015:06:10 09:17:06","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"12","FNumber":2.2,"RecommendedExposureIndex":200,"InteropOffset":4998,"Flash":16,"ExifImageHeight":3840,"WhiteBalance":[],"OffsetSchema":4030,"ExposureTime":0.003125,"SceneCaptureType":[],"ShutterSpeedValue":8.375,"SensitivityType":2,"ExifImageWidth":5760,"LensSerialNumber":"0000415563","MeteringMode":5,"SerialNumber":"022031005945","ExposureProgram":1,"SubSecTime":"12","OwnerName":"","SubSecTimeDigitized":"12"},"gps":{"GPSVersionID":[2,3]},"interoperability":{},"makernote":{}}}}},{"id":"4b51678b-97f3-4d6d-adcd-66fedcf788d8","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Kristen Snipes has over 15 years of pharmaceutical industry experience primarily as a program manager or clinical operations lead. Since joining Rho in 2007, she has been involved in leading and coordinating all operational activities for complex trials. She has a wide range of therapeutic experience including CNS, cardiology, respiratory, periodontal disease, Sjögren’s syndrome, hematology, and oncology programs. Before joining Rho, Kristen worked for a small pharmaceutical company specializing in CNS disorders where she collaborated with scientists and thought leaders in the design, development, implementation and management of a program for a centrally acting alpha2 adrenergic agonist for the treatment of ADHD in children and adolescences. Most recently, she managed a Phase III pivotal study for the treatment of ADHD utilizing the laboratory classroom format. This study completed enrollment two weeks prior to the projected timelines. She is a seasoned team leader with training and mentoring experience having spearheaded multiple training programs in the areas of project and clinical operations management. Kristen has a strong understanding of all aspects of product development that has allowed her to successfully lead teams to meet timeline deliverables for various multi-center trials. She is ACRP and SOCRA certified as a Clinical Research Associate.","_html":"<p>Kristen Snipes has over 15 years of pharmaceutical industry experience primarily as a program manager or clinical operations lead. Since joining Rho in 2007, she has been involved in leading and coordinating all operational activities for complex trials. She has a wide range of therapeutic experience including CNS, cardiology, respiratory, periodontal disease, Sjögren’s syndrome, hematology, and oncology programs. Before joining Rho, Kristen worked for a small pharmaceutical company specializing in CNS disorders where she collaborated with scientists and thought leaders in the design, development, implementation and management of a program for a centrally acting alpha2 adrenergic agonist for the treatment of ADHD in children and adolescences. Most recently, she managed a Phase III pivotal study for the treatment of ADHD utilizing the laboratory classroom format. This study completed enrollment two weeks prior to the projected timelines. She is a seasoned team leader with training and mentoring experience having spearheaded multiple training programs in the areas of project and clinical operations management. Kristen has a strong understanding of all aspects of product development that has allowed her to successfully lead teams to meet timeline deliverables for various multi-center trials. She is ACRP and SOCRA certified as a Clinical Research Associate.</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"e08e4e44-a6da-41b0-a23b-d7f030691de9","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Jamie Arnott","_html":"<p>Jamie Arnott</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"4cedb67d-ee6b-4c2a-bc76-1905ed2a652e","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg","inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/fdd8aa6b2435003f074352fbbcc144cf/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F972dbbf4-cd37-4dfb-aab9-a6111c5c3059.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/394308259e263c8681102b5c1284c7f9.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":111,"y":81,"width":120,"height":120,"confidence":5.024169}],"colors":[[247,251,252],[27,36,45],[228,203,199],[190,163,144],[106,129,51]],"saliency":{"bounding_rect":[[124,50],[226,255]],"confidence":0.193655,"center":[170,153],"radius":106.983},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":5760,"XPKeywords":114,"ExifOffset":2388,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2013:09:05 22:23:09","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":3840,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":5100},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":5242,"ThumbnailLength":4555},"exif":{"ExposureCompensation":[],"ApertureValue":3,"ColorSpace":1,"ISO":100,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2013:08:27 08:41:03","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2013:08:27 08:41:03","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"42","FNumber":2.8,"RecommendedExposureIndex":100,"InteropOffset":4986,"Flash":16,"ExifImageHeight":5760,"WhiteBalance":[],"OffsetSchema":4088,"ExposureTime":0.008,"SceneCaptureType":[],"ShutterSpeedValue":7,"SensitivityType":2,"ExifImageWidth":3840,"LensSerialNumber":"0000415563","MeteringMode":5,"SerialNumber":"022031005945","ExposureProgram":1,"OwnerName":"","SubSecTimeDigitized":"42"},"gps":{"GPSVersionID":[2,3]},"interoperability":{},"makernote":{}}}}},{"id":"06aae7c0-6145-4ee6-8567-25dd6a8f43cb","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Jamie Arnott has extensive experience from her clinical nursing background as well as both the CRO and sponsor perspective in the oversight and management of clinical trial operations and outsourcing with more than 10 years’ experience in project management and 20 years’ experience in healthcare as a practitioner and in clinical research work. Before joining Rho, Jamie was the Director of Clinical Trial Operations for a biotechnology company where she provided oversight and management for all clinical activity for up to four concurrent INDs. She has broad therapeutic experience in oncology, including ovarian cancer, hematological malignancies, and advanced solid tumors; in addition, she has recent experience managing two large phase III studies.","_html":"<p>Jamie Arnott has extensive experience from her clinical nursing background as well as both the CRO and sponsor perspective in the oversight and management of clinical trial operations and outsourcing with more than 10 years’ experience in project management and 20 years’ experience in healthcare as a practitioner and in clinical research work. Before joining Rho, Jamie was the Director of Clinical Trial Operations for a biotechnology company where she provided oversight and management for all clinical activity for up to four concurrent INDs. She has broad therapeutic experience in oncology, including ovarian cancer, hematological malignancies, and advanced solid tumors; in addition, she has recent experience managing two large phase III studies.</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"9e8241a4-e386-4df0-b473-ee883100237d","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"Brett Gordon","_html":"<h2>Brett Gordon</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"d40b0479-5937-4480-b750-4fda8a4914e4","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/d3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg","inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/d3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/d3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/669377f1bf0c6882ca38df9e3177960d/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2Fd3deaca8-5719-40f0-b8ef-72bab2c283c1.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/0011e87ed4bdd7b5d0947c1d9e7bda30.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":77,"y":89,"width":152,"height":152,"confidence":5.017656}],"colors":[[18,22,33],[254,254,254],[204,166,163],[60,75,104],[132,143,103]],"saliency":{"bounding_rect":[[1,213],[299,299]],"confidence":0.584408,"center":[149,278],"radius":154.268},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":5760,"XPKeywords":114,"ExifOffset":2388,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2013:09:05 22:43:01","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":3840,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":5112},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":5254,"ThumbnailLength":4278},"exif":{"ExposureCompensation":[],"ApertureValue":2.375,"ColorSpace":1,"ISO":100,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2013:08:27 08:50:49","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2013:08:27 08:50:49","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"6","FNumber":2.2,"RecommendedExposureIndex":100,"InteropOffset":4998,"Flash":16,"ExifImageHeight":5760,"WhiteBalance":[],"OffsetSchema":4088,"ExposureTime":0.00625,"SceneCaptureType":[],"ShutterSpeedValue":7.375,"SensitivityType":2,"ExifImageWidth":3840,"LensSerialNumber":"0000415563","MeteringMode":5,"SerialNumber":"022031005945","ExposureProgram":1,"SubSecTime":"6","OwnerName":"","SubSecTimeDigitized":"6"},"gps":{"GPSVersionID":[2,3]},"interoperability":{},"makernote":{}}}}},{"id":"126eb6e7-4871-4fe2-a8fa-98eaaa7b6ffb","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Brett Gordon has seventeen years of overall clinical development experience, including thirteen years in project management, encompassing trials of varying sizes and complexity, both domestically and internationally. He has extensive knowledge of clinical development for both drugs/biologics and medical devices, including initial development plan formulation, protocol writing, trial implementation, monitoring and delivery, clinical study report writing, and regulatory submission to support of marketing applications. Brett has worked across numerous therapeutic areas and in particular possesses in-depth CNS and neurological experience, having managed or monitored trials in epilepsy, ADHD, bipolar disorder, alcohol dependence, spinal cord injury, and pain (acute, chronic, neuropathic, and musculoskeletal).","_html":"<p>Brett Gordon has seventeen years of overall clinical development experience, including thirteen years in project management, encompassing trials of varying sizes and complexity, both domestically and internationally. He has extensive knowledge of clinical development for both drugs/biologics and medical devices, including initial development plan formulation, protocol writing, trial implementation, monitoring and delivery, clinical study report writing, and regulatory submission to support of marketing applications. Brett has worked across numerous therapeutic areas and in particular possesses in-depth CNS and neurological experience, having managed or monitored trials in epilepsy, ADHD, bipolar disorder, alcohol dependence, spinal cord injury, and pain (acute, chronic, neuropathic, and musculoskeletal).</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"7ccb2023-dee9-425d-a1bb-f7a64932e873","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"h2","src":null,"created_at":null,"updated_at":null,"_text":"Lauren McGurk","_html":"<h2>Lauren McGurk</h2>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}},{"id":"73612ebc-6c4a-4f20-8ac7-6b5c8dcdaf2d","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"image","created_at":null,"updated_at":null,"_html":"<picture>\n  <source media=\"(min-width: 1440px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300\">\n  <source media=\"(min-width: 1280px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300\">\n  <source media=\"(min-width: 720px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300\">\n  <source media=\"(min-width: 360px)\" srcset=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300\">\n  <img src=\"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300\">\n</picture>\n","metadata":{"@type":"Article","isBasedOnUrl":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/481bd95a-f50d-4f06-9238-f648f62c38b7.jpg","inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]},"cover":{"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300","original":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/481bd95a-f50d-4f06-9238-f648f62c38b7.jpg","imgflosrc":"https://the-grid-user-content.s3-us-west-2.amazonaws.com/481bd95a-f50d-4f06-9238-f648f62c38b7.jpg","pictureImgfloUrls":[{"width":1440,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300"},{"width":1280,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300"},{"width":720,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300"},{"width":360,"src":"https://imgflo.herokuapp.com/graph/vahj1ThiexotieMo/adb172fe54acd60b1fe0569715d399ff/insta_1977.jpg?input=https%3A%2F%2Fthe-grid-user-content.s3-us-west-2.amazonaws.com%2F481bd95a-f50d-4f06-9238-f648f62c38b7.jpg&width=300"}],"resized":"http://the-grid-user-content.s3-us-west-2.amazonaws.com/caliper-resized/e2e6a9ac6e0504b9a58dc7a150c8f793.png","ratio":"1:1","aspect":1,"orientation":"square","width":300,"height":300,"rotation":0,"animated":false,"faces":[{"x":90,"y":63,"width":107,"height":107,"confidence":5.034669}],"colors":[[16,19,24],[171,208,105],[221,193,205],[78,124,96],[181,106,103]],"saliency":{"bounding_rect":[[99,39],[238,299]],"confidence":0.361164,"center":[181,168],"radius":145.322},"exif":{"exif":{"image":{"BitsPerSample":[8,8,8],"ImageHeight":3840,"XPKeywords":97,"ExifOffset":2388,"XResolution":72,"YResolution":72,"Software":"Adobe Photoshop CS5 Windows","ModifyDate":"2014:08:18 00:12:46","Model":"Canon EOS 5D Mark III","PhotometricInterpretation":2,"ImageWidth":5760,"Make":"Canon","ResolutionUnit":2,"Orientation":1,"SamplesPerPixel":3,"YCbCrPositioning":2,"GPSInfo":5112},"thumbnail":{"Compression":6,"XResolution":72,"YResolution":72,"ResolutionUnit":2,"ThumbnailOffset":5248,"ThumbnailLength":4427},"exif":{"ExposureCompensation":[],"ApertureValue":3,"ColorSpace":1,"ISO":160,"CustomRendered":[],"FocalPlaneResolutionUnit":2,"CreateDate":"2014:08:12 10:12:02","ExposureMode":1,"LensModel":"EF50mm f/1.2L USM","FocalLength":50,"DateTimeOriginal":"2014:08:12 10:12:02","LensInfo":[50,50],"FocalPlaneXResolution":3942.5051334702257,"FocalPlaneYResolution":3950.617283950617,"SubSecTimeOriginal":"09","FNumber":2.8,"RecommendedExposureIndex":160,"InteropOffset":4998,"Flash":16,"ExifImageHeight":3840,"WhiteBalance":[],"OffsetSchema":4030,"ExposureTime":0.002,"SceneCaptureType":[],"ShutterSpeedValue":9,"SensitivityType":2,"ExifImageWidth":5760,"LensSerialNumber":"0000415563","MeteringMode":5,"SerialNumber":"022031005945","ExposureProgram":1,"SubSecTime":"09","OwnerName":"","SubSecTimeDigitized":"09"},"gps":{"GPSVersionID":[2,3]},"interoperability":{},"makernote":{}}}}},{"id":"a35b1d86-09f9-4df7-b4ea-6d46f9088493","item":"91d20fd0-2eb3-4156-beab-ff0f38e2aa29","type":"text","src":null,"created_at":null,"updated_at":null,"_text":"Lauren McGurk has over 17 years of industry and clinical research experience in all phases of development, serving in the roles of Lead/Senior CRA, Site Manager, and Auditor. Since joining Rho in 2011, she has been involved in leading and conducting the clinical monitoring efforts on a variety of complex trials including a suite of dental-themed studies, including but not limited to periodontitis, TMJ and oral health disparities, hypoparathyroidism, head and neck oncology, refractory oncology pain, and parotid dysfunction. In addition to her role as LCRA, she has extensive EDC experience in a host of electronic capture systems, and has served as a site trainer and “train the trainer” for monitoring and other staff. She is a seasoned clinical team leader with training and mentoring experience and serves as a clinical and regulatory resource for her teams. Lauren has a strong understanding of clinical trial operations and management that has allowed her to successfully lead clinical teams to meet data timeline deliverables for various multi-center trials. She is adept in all aspects of GCPs, regulatory requirements, and site management.","_html":"<p>Lauren McGurk has over 17 years of industry and clinical research experience in all phases of development, serving in the roles of Lead/Senior CRA, Site Manager, and Auditor. Since joining Rho in 2011, she has been involved in leading and conducting the clinical monitoring efforts on a variety of complex trials including a suite of dental-themed studies, including but not limited to periodontitis, TMJ and oral health disparities, hypoparathyroidism, head and neck oncology, refractory oncology pain, and parotid dysfunction. In addition to her role as LCRA, she has extensive EDC experience in a host of electronic capture systems, and has served as a site trainer and “train the trainer” for monitoring and other staff. She is a seasoned clinical team leader with training and mentoring experience and serves as a clinical and regulatory resource for her teams. Lauren has a strong understanding of clinical trial operations and management that has allowed her to successfully lead clinical teams to meet data timeline deliverables for various multi-center trials. She is adept in all aspects of GCPs, regulatory requirements, and site management.</p>","metadata":{"isBasedOnUrl":null,"inLanguage":null,"starred":false,"inFeed":true,"hasPage":false,"inNav":false,"_description":"","keywords":[]}}]},"site-footer-item":{"id":"site-footer-item","index":2,"metadata":{"@type":"footer","starred":true},"content":[{"id":"site-footer-block","type":"footer","_html":"","metadata":{"starred":true},"footer":{"rss":{"href":"rss.xml","rel":"alternate","title":"Rho test site RSS","type":"application/rss+xml"}}}]}},"sections":[{"componentId":"ArticleFallback","itemsToRenderIds":["91d20fd0-2eb3-4156-beab-ff0f38e2aa29"],"contracts":{"the-beautician":{"$item_index":1,"sectionsBeautyverse":{"section-height":{"$class":["section-height-fullscreen"]},"text-align":{"$class":["text-align-center"]},"group-order":{"$class":["group-order-normal"]},"group-graphical-shape":{"$class":["group-graphical-shape-none"]}},"$class":["group-graphical-shape-none","group-order-normal","text-align-center","section-height-fullscreen","site:w-multiple-item","nav-general-style","hero-transition-none","section-v-padding-small","section-h-padding-small","Brockmann","site-navigation-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-navigation","NavHamburger","91d20fd0-2eb3-4156-beab-ff0f38e2aa29","ArticleFallback","site-footer-item","item:is-footer","Footer3col"]},"the-colorist":{"$item_index":1,"colorverse":{"colors-solution":{"color":"dark","$class":["colors-dark"]},"colors-locality":{"locality":"local","$class":["colors-local"]}},"$class":["colors-local","colors-dark","site:colors-global","site:colors-light"],"colorsSolution":{"isLight":false,"isDark":true,"lightnessClass":"is-dark","base":{"r":20,"g":22,"b":26},"bg":{"r":18,"g":20,"b":23},"box":{"r":20,"g":22,"b":26},"boxShadow":{"r":0,"g":0,"b":0,"a":0.3},"boxPop":{"r":204,"g":40,"b":49},"boxPopText":{"r":255,"g":255,"b":255},"boxPop2":{"r":0,"g":166,"b":81},"boxPop2Text":{"r":255,"g":255,"b":255},"boxPopTextHover":{"r":204,"g":204,"b":204},"boxPop2TextHover":{"r":204,"g":204,"b":204},"boxPopMostVibrant":{"r":0,"g":166,"b":81},"boxPopMostVibrantText":{"r":255,"g":255,"b":255},"selectionText":{"r":255,"g":255,"b":255},"selection":{"r":0,"g":166,"b":81,"a":0.5},"header":{"r":19,"g":21,"b":25},"zebraStripe":{"r":23,"g":25,"b":29},"line":{"r":37,"g":39,"b":43},"mediaBorder":{"css":"1px solid hsl(220, 8%, 16%)","width":1,"type":"solid","color":{"r":37,"g":39,"b":43}},"mediaShadowColor":{"r":0,"g":0,"b":0,"a":0.4},"mediaInsetColor":{"r":255,"g":255,"b":255,"a":0.1},"mediaShadows":[{"css":"0 1px 2px rgba(0, 0, 0, 0.4)","x":0,"y":1,"blur":2,"color":{"r":0,"g":0,"b":0,"a":0.4},"inset":false},{"css":"inset 0 1px 1px rgba(255, 255, 255, 0.1)","x":0,"y":1,"blur":1,"color":{"r":255,"g":255,"b":255,"a":0.1},"inset":true}],"title":{"r":204,"g":255,"b":229},"title2":{"r":149,"g":185,"b":168},"subTitle":{"r":87,"g":88,"b":91},"text":{"r":241,"g":242,"b":244},"text2":{"r":175,"g":176,"b":179},"textShadow":{"r":11,"g":12,"b":14,"a":0.5},"textShadowProps":{"color":{"r":11,"g":12,"b":14,"a":0.5},"x":0,"y":1,"blur":0},"textPop":{"r":41,"g":180,"b":109},"textPop2":{"r":213,"g":78,"b":85},"meta":{"r":87,"g":88,"b":91},"metaHover":{"r":100,"g":101,"b":104},"icon":{"r":41,"g":180,"b":109},"iconSelected":{"r":41,"g":180,"b":109},"iconOver":{"r":41,"g":180,"b":109},"palette":[{"r":222,"g":222,"b":222},{"r":20,"g":22,"b":26},{"r":139,"g":137,"b":132},{"r":0,"g":166,"b":81},{"r":204,"g":40,"b":49}]}},"the-lensman":{"filter":{"$class":["insta_1977"],"graph":"insta_1977","config":null}},"itemsClasses":["91d20fd0-2eb3-4156-beab-ff0f38e2aa29","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay"],"siteClasses":["site:w-multiple-item","nav-general-style","hero-transition-none","section-v-padding-small","section-h-padding-small","Brockmann","site-navigation-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-navigation","NavHamburger","91d20fd0-2eb3-4156-beab-ff0f38e2aa29","ArticleFallback","site-footer-item","item:is-footer","Footer3col","site:colors-global","site:colors-light"],"componentClasses":["ArticleFallback"]},"sectionIndex":0}],"contracts":{"the-typographer":{"typography":{"fonts":{"display":{"$formality":-0.4545454545454546,"$type":["sans","humanist"],"$weight":2,"$width":2,"$xheight":2,"$contrast":2,"$caps":"normal","family":"Alegreya Sans","name":"Alegreya Sans","foundry":"google","license":"ofl","similar_to":["Calluna Sans","FF Scala Sans"],"description":"Alegreya Sans is a humanist sans serif family with a calligraphic feeling\nthat conveys a dynamic and varied rhythm. This gives a pleasant feeling to\nreaders of long texts.\n\nThe family follows humanist proportions and principles, just like the serif\nversion of the family, Alegreya. It achieves a ludic and harmonious\nparagraph through elements carefully designed in an atmosphere of\ndiversity.\n\nThe italics bring a strong emphasis to the roman styles, and each have\nseven weights to bring you a wide typographic palette.","links":["https://www.google.com/fonts/specimen/Alegreya+Sans","https://www.typewolf.com/site-of-the-day/fonts/alegreya-sans"],"normal":4,"bold":9},"screen":{"$formality":0.4545454545454546,"$type":["serif","old-style"],"$weight":2,"$width":2,"$xheight":2,"$contrast":2,"$caps":"normal","family":"Alegreya","name":"Alegreya","foundry":"google","license":"ofl","similar_to":["Lapture","Schneidler"],"description":"Alegreya was chosen as one of 53 \"Fonts of the Decade\" at the ATypI Letter2\ncompetition in September 2011, and one of the top 14 text type systems. It\nwas also selected in the 2nd Bienal Iberoamericana de Diseño, competition\nheld in Madrid in 2010.\n\nAlegreya is a typeface originally intended for literature. Among its\ncrowning characteristics, it conveys a dynamic and varied rhythm which\nfacilitates the reading of long texts. Also, it provides freshness to the\npage while referring to the calligraphic letter, not as a literal\ninterpretation, but rather in a contemporary typographic language.","links":["https://www.google.com/fonts/specimen/Alegreya","https://www.typewolf.com/site-of-the-day/fonts/alegreya"],"normal":4,"bold":7}},"styles":"html { font-family: 'Georgia', 'Times New Roman', 'Times', 'serif';font-weight: 400; } html.wf-active { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif';font-weight: 400; } .wf-active .font-title, .wf-active .font-headline, .wf-active .font-h1, .wf-active .font-h2, .wf-active .font-h3 { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 900; } .wf-active .font-subtitle, .wf-active .font-h4, .wf-active .font-h5, .wf-active .font-h6 { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 900; } .wf-active .font-text, .wf-active .font-list { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif'; } .wf-active .font-quote { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 400;font-style: italic; } .wf-active .font-cta { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif'; }","webfontconfig":{"google":{"families":["Alegreya Sans:400,900","Alegreya:400,400italic,700,700italic"]}}},"htmlStyleTagContent":"html { font-family: 'Georgia', 'Times New Roman', 'Times', 'serif';font-weight: 400; } html.wf-active { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif';font-weight: 400; } .wf-active .font-title, .wf-active .font-headline, .wf-active .font-h1, .wf-active .font-h2, .wf-active .font-h3 { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 900; } .wf-active .font-subtitle, .wf-active .font-h4, .wf-active .font-h5, .wf-active .font-h6 { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 900; } .wf-active .font-text, .wf-active .font-list { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif'; } .wf-active .font-quote { font-family: 'Alegreya Sans', '-apple-system', '.SFNSText-Regular', 'San Francisco', 'Roboto', 'Segoe UI', 'Helvetica Neue', 'Lucida Grande', 'sans-serif';font-weight: 400;font-style: italic; } .wf-active .font-cta { font-family: 'Alegreya', 'Georgia', 'Times New Roman', 'Times', 'serif'; }","htmlScriptTagContent":"\n      if (window.WebFont) {\n        WebFont.load({\"google\":{\"families\":[\"Alegreya Sans:400,900\",\"Alegreya:400,400italic,700,700italic\"]}});\n      }\n    "},"the-beautician":{"$item_index":0,"siteBeautyverse":{"design-style":{"$class":["Brockmann"]},"section-h-padding":{"$class":["section-h-padding-small"]},"section-v-padding":{"$class":["section-v-padding-small"]},"hero-transition":{"$class":["hero-transition-none"]},"navigation-style":{"$class":["nav-general-style"],"css":"m-t-4"}},"$class":["nav-general-style","hero-transition-none","section-v-padding-small","section-h-padding-small","Brockmann","site:w-multiple-item","site-navigation-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-navigation","NavHamburger","91d20fd0-2eb3-4156-beab-ff0f38e2aa29","ArticleFallback","site-footer-item","item:is-footer","Footer3col"]},"the-colorist":{"$item_index":0,"colorverse":{"colors-solution":{"color":"light","$class":["colors-light"]},"colors-locality":{"locality":"global","$class":["colors-global"]}},"$class":["colors-global","colors-light","site:w-multiple-item"],"colorsSolution":{"isLight":true,"isDark":false,"lightnessClass":"is-light","base":{"r":222,"g":222,"b":222},"bg":{"r":234,"g":234,"b":234},"box":{"r":242,"g":242,"b":242},"boxShadow":{"r":0,"g":0,"b":0,"a":0.1},"boxPop":{"r":0,"g":166,"b":81},"boxPopText":{"r":255,"g":255,"b":255},"boxPop2":{"r":204,"g":40,"b":49},"boxPop2Text":{"r":255,"g":255,"b":255},"boxPopTextHover":{"r":204,"g":204,"b":204},"boxPop2TextHover":{"r":204,"g":204,"b":204},"boxPopMostVibrant":{"r":0,"g":166,"b":81},"boxPopMostVibrantText":{"r":255,"g":255,"b":255},"selectionText":{"r":0,"g":0,"b":0},"selection":{"r":241,"g":181,"b":30,"a":0.5},"header":{"r":240,"g":240,"b":240},"zebraStripe":{"r":239,"g":239,"b":239},"line":{"r":226,"g":226,"b":226},"mediaBorder":{"css":"1px solid hsl(0, 0%, 89%)","width":1,"type":"solid","color":{"r":226,"g":226,"b":226}},"mediaShadowColor":{"r":0,"g":0,"b":0,"a":0.2},"mediaInsetColor":{"r":255,"g":255,"b":255,"a":0.1},"mediaShadows":[{"css":"0 1px 2px rgba(0, 0, 0, 0.2)","x":0,"y":1,"blur":2,"color":{"r":0,"g":0,"b":0,"a":0.2},"inset":false},{"css":"inset 0 1px 1px rgba(255, 255, 255, 0.1)","x":0,"y":1,"blur":1,"color":{"r":255,"g":255,"b":255,"a":0.1},"inset":true}],"title":{"r":53,"g":52,"b":49},"title2":{"r":110,"g":109,"b":107},"subTitle":{"r":175,"g":176,"b":177},"text":{"r":20,"g":22,"b":26},"text2":{"r":131,"g":132,"b":134},"textShadow":{"r":255,"g":255,"b":255,"a":0.5},"textShadowProps":{"color":{"r":255,"g":255,"b":255,"a":0.5},"x":0,"y":1,"blur":0},"textPop":{"r":173,"g":34,"b":42},"textPop2":{"r":0,"g":141,"b":69},"meta":{"r":175,"g":176,"b":177},"metaHover":{"r":149,"g":150,"b":151},"icon":{"r":173,"g":34,"b":42},"iconSelected":{"r":173,"g":34,"b":42},"iconOver":{"r":173,"g":34,"b":42},"palette":[{"r":222,"g":222,"b":222},{"r":20,"g":22,"b":26},{"r":139,"g":137,"b":132},{"r":0,"g":166,"b":81},{"r":204,"g":40,"b":49}]}}},"siteData":{"id":"fe30b8e0-54cd-4394-b2ba-cf2fb5a79d47","ordered":true,"site":"the-domains/rho-test-site","title":"Featured Experts","navigable":false,"type":"permalink","siteUrl":"https://thegrid.ai/rho-test-site/","siteId":"624b2363-1a00-458d-b68b-7a2c9307841e","user":"dc6bef21-7e20-4732-bcfa-e43d2d8cc714","config":{"name":"Rho test site","style":"the-composer","favicon":null,"cta":{"domain":null,"bucket":null,"version":null},"analytics":{"google":null,"facebook":null,"twitter":null},"opengraph":{"image":null,"type":null,"appId":null},"collections":[{"index":{"path":"/","number":15,"navigable":true,"paginate":true},"feed":{"path":"/rss.xml","format":"rss","number":10},"permalink":{"path":"/:title/"}}],"color":{"brandColors":["#dedede","#14161a","#8b8984","#00a651","#cc2831"],"brandStrength":0.125,"lightness":0.5,"saturation":0.5,"rhythmicContrast":0.5},"layout_spectrum":0.1668,"typography_spectrum":0.7312140280846506},"navigation":[{"href":"index.html","title":"Rho test site","rel":"home","type":"MainPage"},{"href":"meet-the-team/index.html","title":"Meet the Team","rel":"","type":"WebPage"},{"href":"contact-us/index.html","title":"Contact Us","rel":"","type":"WebPage"},{"href":"solutions/index.html","title":"Solutions","rel":"","type":"WebPage"}],"links":[{"href":"rss.xml","rel":"alternate","title":"Rho test site RSS","type":"application/rss+xml"}]},"navigation":{"componentId":"NavHamburger","itemsToRenderIds":["site-navigation-item"],"contracts":{"the-beautician":{"$item_index":0,"sectionsBeautyverse":{"section-height":{"$class":["section-height-fullscreen"]},"text-align":{"$class":["text-align-center"]},"group-order":{"$class":["group-order-normal"]},"group-graphical-shape":{"$class":["group-graphical-shape-none"]}},"$class":["group-graphical-shape-none","group-order-normal","text-align-center","section-height-fullscreen","site:w-multiple-item","nav-general-style","hero-transition-none","section-v-padding-small","section-h-padding-small","Brockmann","site-navigation-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-navigation","NavHamburger","91d20fd0-2eb3-4156-beab-ff0f38e2aa29","ArticleFallback","site-footer-item","item:is-footer","Footer3col"]},"the-colorist":{"$item_index":0,"colorverse":{"colors-solution":{"color":"light","$class":["colors-light"]},"colors-locality":{"locality":"local","$class":["colors-local"]}},"$class":["colors-local","colors-light","site:colors-global","site:colors-light"],"colorsSolution":{"isLight":true,"isDark":false,"lightnessClass":"is-light","base":{"r":222,"g":222,"b":222},"bg":{"r":234,"g":234,"b":234},"box":{"r":242,"g":242,"b":242},"boxShadow":{"r":0,"g":0,"b":0,"a":0.1},"boxPop":{"r":0,"g":166,"b":81},"boxPopText":{"r":255,"g":255,"b":255},"boxPop2":{"r":204,"g":40,"b":49},"boxPop2Text":{"r":255,"g":255,"b":255},"boxPopTextHover":{"r":204,"g":204,"b":204},"boxPop2TextHover":{"r":204,"g":204,"b":204},"boxPopMostVibrant":{"r":0,"g":166,"b":81},"boxPopMostVibrantText":{"r":255,"g":255,"b":255},"selectionText":{"r":0,"g":0,"b":0},"selection":{"r":241,"g":181,"b":30,"a":0.5},"header":{"r":240,"g":240,"b":240},"zebraStripe":{"r":239,"g":239,"b":239},"line":{"r":226,"g":226,"b":226},"mediaBorder":{"css":"1px solid hsl(0, 0%, 89%)","width":1,"type":"solid","color":{"r":226,"g":226,"b":226}},"mediaShadowColor":{"r":0,"g":0,"b":0,"a":0.2},"mediaInsetColor":{"r":255,"g":255,"b":255,"a":0.1},"mediaShadows":[{"css":"0 1px 2px rgba(0, 0, 0, 0.2)","x":0,"y":1,"blur":2,"color":{"r":0,"g":0,"b":0,"a":0.2},"inset":false},{"css":"inset 0 1px 1px rgba(255, 255, 255, 0.1)","x":0,"y":1,"blur":1,"color":{"r":255,"g":255,"b":255,"a":0.1},"inset":true}],"title":{"r":53,"g":52,"b":49},"title2":{"r":110,"g":109,"b":107},"subTitle":{"r":175,"g":176,"b":177},"text":{"r":20,"g":22,"b":26},"text2":{"r":131,"g":132,"b":134},"textShadow":{"r":255,"g":255,"b":255,"a":0.5},"textShadowProps":{"color":{"r":255,"g":255,"b":255,"a":0.5},"x":0,"y":1,"blur":0},"textPop":{"r":173,"g":34,"b":42},"textPop2":{"r":0,"g":141,"b":69},"meta":{"r":175,"g":176,"b":177},"metaHover":{"r":149,"g":150,"b":151},"icon":{"r":173,"g":34,"b":42},"iconSelected":{"r":173,"g":34,"b":42},"iconOver":{"r":173,"g":34,"b":42},"palette":[{"r":222,"g":222,"b":222},{"r":20,"g":22,"b":26},{"r":139,"g":137,"b":132},{"r":0,"g":166,"b":81},{"r":204,"g":40,"b":49}]}},"the-lensman":{"filter":{"$class":["insta_1977"],"graph":"insta_1977","config":null}},"itemsClasses":["site-navigation-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-navigation"],"siteClasses":["site:w-multiple-item","nav-general-style","hero-transition-none","section-v-padding-small","section-h-padding-small","Brockmann","site-navigation-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-navigation","NavHamburger","91d20fd0-2eb3-4156-beab-ff0f38e2aa29","ArticleFallback","site-footer-item","item:is-footer","Footer3col","site:colors-global","site:colors-light"],"componentClasses":["NavHamburger"]}},"footer":{"componentId":"Footer3col","itemsToRenderIds":["site-footer-item"],"contracts":{"the-beautician":{"$item_index":2,"sectionsBeautyverse":{"section-height":{"$class":["section-height-fullscreen"]},"text-align":{"$class":["text-align-center"]},"group-order":{"$class":["group-order-normal"]},"group-graphical-shape":{"$class":["group-graphical-shape-circle"]}},"$class":["group-graphical-shape-circle","group-order-normal","text-align-center","section-height-fullscreen","site:w-multiple-item","nav-general-style","hero-transition-none","section-v-padding-small","section-h-padding-small","Brockmann","site-navigation-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-navigation","NavHamburger","91d20fd0-2eb3-4156-beab-ff0f38e2aa29","ArticleFallback","site-footer-item","item:is-footer","Footer3col"]},"the-colorist":{"$item_index":2,"colorverse":{"colors-solution":{"color":"dark","$class":["colors-dark"]},"colors-locality":{"locality":"local","$class":["colors-local"]}},"$class":["colors-local","colors-dark","site:colors-global","site:colors-light"],"colorsSolution":{"isLight":false,"isDark":true,"lightnessClass":"is-dark","base":{"r":20,"g":22,"b":26},"bg":{"r":18,"g":20,"b":23},"box":{"r":20,"g":22,"b":26},"boxShadow":{"r":0,"g":0,"b":0,"a":0.3},"boxPop":{"r":204,"g":40,"b":49},"boxPopText":{"r":255,"g":255,"b":255},"boxPop2":{"r":0,"g":166,"b":81},"boxPop2Text":{"r":255,"g":255,"b":255},"boxPopTextHover":{"r":204,"g":204,"b":204},"boxPop2TextHover":{"r":204,"g":204,"b":204},"boxPopMostVibrant":{"r":0,"g":166,"b":81},"boxPopMostVibrantText":{"r":255,"g":255,"b":255},"selectionText":{"r":255,"g":255,"b":255},"selection":{"r":0,"g":166,"b":81,"a":0.5},"header":{"r":19,"g":21,"b":25},"zebraStripe":{"r":23,"g":25,"b":29},"line":{"r":37,"g":39,"b":43},"mediaBorder":{"css":"1px solid hsl(220, 8%, 16%)","width":1,"type":"solid","color":{"r":37,"g":39,"b":43}},"mediaShadowColor":{"r":0,"g":0,"b":0,"a":0.4},"mediaInsetColor":{"r":255,"g":255,"b":255,"a":0.1},"mediaShadows":[{"css":"0 1px 2px rgba(0, 0, 0, 0.4)","x":0,"y":1,"blur":2,"color":{"r":0,"g":0,"b":0,"a":0.4},"inset":false},{"css":"inset 0 1px 1px rgba(255, 255, 255, 0.1)","x":0,"y":1,"blur":1,"color":{"r":255,"g":255,"b":255,"a":0.1},"inset":true}],"title":{"r":204,"g":255,"b":229},"title2":{"r":149,"g":185,"b":168},"subTitle":{"r":87,"g":88,"b":91},"text":{"r":241,"g":242,"b":244},"text2":{"r":175,"g":176,"b":179},"textShadow":{"r":11,"g":12,"b":14,"a":0.5},"textShadowProps":{"color":{"r":11,"g":12,"b":14,"a":0.5},"x":0,"y":1,"blur":0},"textPop":{"r":41,"g":180,"b":109},"textPop2":{"r":213,"g":78,"b":85},"meta":{"r":87,"g":88,"b":91},"metaHover":{"r":100,"g":101,"b":104},"icon":{"r":41,"g":180,"b":109},"iconSelected":{"r":41,"g":180,"b":109},"iconOver":{"r":41,"g":180,"b":109},"palette":[{"r":222,"g":222,"b":222},{"r":20,"g":22,"b":26},{"r":139,"g":137,"b":132},{"r":0,"g":166,"b":81},{"r":204,"g":40,"b":49}]}},"the-lensman":{"filter":{"$class":["insta_brannan"],"graph":"insta_brannan","config":null}},"itemsClasses":["site-footer-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-footer"],"siteClasses":["site:w-multiple-item","nav-general-style","hero-transition-none","section-v-padding-small","section-h-padding-small","Brockmann","site-navigation-item","item:can-cover-filter","item:can-cover-crop","item:can-cover-overlay","item:is-navigation","NavHamburger","91d20fd0-2eb3-4156-beab-ff0f38e2aa29","ArticleFallback","site-footer-item","item:is-footer","Footer3col","site:colors-global","site:colors-light"],"componentClasses":["Footer3col"]}}}</script><script id="renderer" src="https://cdn.thegrid.io/design-systems/the-composer/ds-nj/v1.1.7/ds-renderer.js"></script><script id="web-font-loader">
      if (window.WebFont) {
        WebFont.load({"google":{"families":["Alegreya Sans:400,900","Alegreya:400,400italic,700,700italic"]}});
      }
    </script></body></html>